Evidence map›Paper›PMID 37049269›Full record

ArticleNanomaterials (Basel, Switzerland)2023

Enhanced Diffractive Circular Dichroism from Stereoscopic Plasmonic Molecule Array.

Liangliang Gu, Rong Shu, Xiangfeng Liu, Haifeng Hu, Qiwen Zhan

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Liangliang GuSchool of Optical-Electrical and Computer Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.
Rong ShuKey Laboratory of Space Active Opto-Electronics Technology, Shanghai Institute of Technical Physics, Chinese Academy of Sciences, Shanghai 200083, China.
Xiangfeng LiuKey Laboratory of Space Active Opto-Electronics Technology, Shanghai Institute of Technical Physics, Chinese Academy of Sciences, Shanghai 200083, China.ORCID 0000-0002-6821-449X
Haifeng HuSchool of Optical-Electrical and Computer Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.ORCID 0000-0002-9447-1481
Qiwen ZhanSchool of Optical-Electrical and Computer Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.ORCID 0000-0001-8745-4213

Funding

National Natural Science Foundation of China 62005168, 62075132, 92050202Natural Science Foundation of Shanghai 22ZR1443100
6 · The paper itself

Abstract

Artificial nanostructures with large optical chiral responses have been intensively investigated recently. In this work, we propose a diffractive circular dichroism enhancement technique using stereoscopic plasmonic molecule structures. According to the multipole expansion analysis, the z-component of the electric dipole becomes the dominant chiral scattering mechanism during the interaction between an individual plasmonic molecule and the plane wave at a grazing angle. For a periodical structure with the designed plasmonic molecule, large diffractive circular dichroism can be obtained, which can be associated with the Wood-Rayleigh anomaly. Such a diffractive circular dichroism enhancement is verified by the good agreement between numerical simulations and experimental results. The proposed approach can be potentially used to develop enhanced spectroscopy techniques to measure chiral information, which is very important for fundamental physical and chemical research and bio-sensing applications.

Indexed as

ChiralityCircular DichroismLight DiffractionMultipole Expansionplasmonics

Identifiers

PMID37049269
PMCPMC10096713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.